• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Bagger Dave's Burger Tavern Inc
CSW Industrials, Inc. Common Stock
Castellum, Inc. Common Stock
Citic Ltd Ord
Farmers & Merchants Bancorp
Ishares Core MSCI CAD Qlty Div Idx ETF
Medpace Holdings, Inc. - Common Stock
Mercari Inc
Metalore Resources Limited
MyMD Pharmaceuticals, Inc. - Common Stock
PFSweb, Inc. - Common Stock
Planet Resource Reco
Portage Biotech Inc. - Common Stock
RES. MIN. RADISS
Sage Group ADR
Snail, Inc. - Class A Common Stock
Supremex Inc
Tokyo Tatemono Company Ltd
Verses AI Inc
Edit Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ovid Therapeutics Inc. - Common Stock (NQ:OVID)

2.150 -0.110 (-4.87%)
Delayed Quote Updated: 4:00 PM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,325,435
Open 2.260
Bid (Size) 2.110 (600)
Ask (Size) 2.650 (400)
Prev. Close 2.260
Today's Range 2.110 - 2.300
52wk Range 1.180 - 3.105
Shares Outstanding 70,417,345
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What's going on in today's after hours session ↗
October 01, 2026
Via Chartmill
News headline image
Ovid Therapeutics to Participate in Upcoming Investor Conferences
September 03, 2026
From Ovid Therapeutics Inc.
Via GlobeNewswire

Performance

52-Week Range 30.8% below 52-week high
2.150
1.1852W Low 3.1052W High
1 Week 13.8% below 1-week high
2.091W Low 2.491W High

Ovid Therapeutics Inc. - Common Stock (OVID) traded between $1.18 and $3.10 over the past 52 weeks and last traded at $2.15, 30.8% below its 52-week high. Over the past week it ranged between $2.09 and $2.49.

Past 12 Months
-10.8%
-19.8%
-11.9%
-26.1%
+22.2%
+36.9%
1W -$0.26
1M -$0.53
3M -$0.29
6M -$0.76
YTD +$0.39
1Y +$0.58

OVID was +36.9% over the past year, -26.1% over six months, +22.2% year to date, -10.8% in the last week.

12 Months vs Market
OVID
+36.9%
DIA
+13.0%
SPY
+15.5%
QQQ
+18.3%
IWM
+10.4%

Over the past 12 months OVID returned +36.9% versus DIA (Dow) +13.0%, SPY (S&P 500) +15.5%, QQQ (Nasdaq 100) +18.3% and IWM (Russell 2000) +10.4%.

Volume & Liquidity 0.84× 3-mo avg
Today 1,325,435 3-mo avg 1.6M
1W
1.4M
1M
1.8M
3M
1.6M
6M
2.0M
YTD
2.3M
1Y
2.1M

OVID most recently traded 1,325,435 shares against a 3-month average daily volume of 1.6M.

More News

Read More
News headline image
Ovid Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results
August 13, 2026
From Ovid Therapeutics Inc.
Via GlobeNewswire
News headline image
Ovid Therapeutics Strengthens Executive Leadership Team to Support Continued Pipeline Progress and Next Phase of Development
July 08, 2026
From Ovid Therapeutics Inc.
Via GlobeNewswire
OVID Therapeutics Inc (NASDAQ:OVID) Passes Minervini's High-Growth Momentum and Trend Template Filters ↗
March 30, 2026
Via Chartmill
News headline image
Ovid Therapeutics to Participate in Upcoming Investor Conferences
June 04, 2026
From Ovid Therapeutics Inc.
Via GlobeNewswire
News headline image
Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors
June 03, 2026
From Ovid Therapeutics Inc.
Via GlobeNewswire
News headline image
Ovid Therapeutics Reports Business Updates and First Quarter 2026 Financial Results
May 12, 2026
From Ovid Therapeutics Inc.
Via GlobeNewswire
News headline image
Here's Why Ovid Therapeutics Stock Popped Higher Today ↗
March 18, 2026
Via The Motley Fool
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
March 18, 2026
Via Chartmill
Discover the top movers in Wednesday's pre-market session. ↗
March 18, 2026
Via Chartmill
News headline image
Ovid Therapeutics Announces New OV329 Data and Indication Expansion, Phase 1 Clearance for OV4071, and Reports Fourth Quarter and Full Year 2025 Financial Results
March 18, 2026
From Ovid Therapeutics Inc.
Via GlobeNewswire
News headline image
Ovid Therapeutics Announces Pricing of $60 Million Private Placement
March 18, 2026
From Ovid Therapeutics Inc.
Via GlobeNewswire
News headline image
Ovid Therapeutics to Participate in Upcoming Investor Conferences
February 25, 2026
From Ovid Therapeutics Inc.
Via GlobeNewswire
News headline image
Ovid Therapeutics Reports Phase 1 Results for the First-Ever Direct Activator of Potassium-Chloride Cotransporter 2 (KCC2), OV350 Intravenous (IV)
December 18, 2025
From Ovid Therapeutics Inc.
Via GlobeNewswire
News headline image
Ovid Therapeutics Appoints Dr. Petra Kaufmann as Chief Medical Officer
December 02, 2025
From Ovid Therapeutics Inc.
Via GlobeNewswire
News headline image
This Alto Neuroscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
November 17, 2025
Via Benzinga
News headline image
OVID THERAPEUTICS INC (NASDAQ:OVID) Announces Leadership Transition and Key Pipeline Milestones Following Q3 2025 Results ↗
November 12, 2025
Via Chartmill
News headline image
Ovid Therapeutics Announces Planned Leadership Succession and Reports Business Updates and Third Quarter 2025 Financial Results
November 12, 2025
From Ovid Therapeutics Inc.
Via GlobeNewswire
News headline image
Curious about the stocks that are showing activity after the closing bell on Friday? ↗
October 03, 2025
Via Chartmill
News headline image
Ovid Therapeutics Stock Rallied 18% Pre-Market – Here’s Why ↗
October 03, 2025
Via Stocktwits
Topics Intellectual Property
News headline image
These stocks that are showing activity before the opening bell on Friday. ↗
October 03, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
October 03, 2025
Via Benzinga
News headline image
Ovid Therapeutics Announces Pricing of Private Placement Totaling up to $175 Million in Gross Proceeds
October 03, 2025
From Ovid Therapeutics Inc.
Via GlobeNewswire
News headline image
Ovid announces positive topline results for the next-generation GABA-aminotransferase inhibitor, OV329, that demonstrate strong inhibitory activity and a potential best-in-category safety profile
October 03, 2025
From Ovid Therapeutics Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Ovid Therapeutics Inc. - Common Stock publicly traded?
Yes, Ovid Therapeutics Inc. - Common Stock is publicly traded.
What exchange does Ovid Therapeutics Inc. - Common Stock trade on?
Ovid Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Ovid Therapeutics Inc. - Common Stock?
The ticker symbol for Ovid Therapeutics Inc. - Common Stock is OVID on the Nasdaq Stock Market
What is the current price of Ovid Therapeutics Inc. - Common Stock?
The current price of Ovid Therapeutics Inc. - Common Stock is 2.150
When was Ovid Therapeutics Inc. - Common Stock last traded?
The last trade of Ovid Therapeutics Inc. - Common Stock was at 10/16/26 04:00 PM ET
What is the market capitalization of Ovid Therapeutics Inc. - Common Stock?
The market capitalization of Ovid Therapeutics Inc. - Common Stock is 151.40M
How many shares of Ovid Therapeutics Inc. - Common Stock are outstanding?
Ovid Therapeutics Inc. - Common Stock has 151M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap